Skip to content

Effect of Dexmedetomidine on elevated blood pressure inside operation theatre: A randomized comparative study

Effect of Dexmedetomidine on elevated blood pressure inside operation theatre: A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/044537
Enrollment
60
Registered
2022-08-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z761- Encounter for health supervision and care of foundling

Interventions

Intervention1: Dexmedetomidine: 0.5 micrograms dexmedetomidine before induction for 5 min Control Intervention1: Dexmedetomidine : 0.25 micrograms dexmedetomidine before induction over 5 min

Sponsors

Department of Anaesthesiology
Lead Sponsor
Department of Anaesthesiology
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Normotensive in evening before surgery PAC with no H/O hypertension 2.Patients of either sex, aged 20-50 years 3.Presence of elevated blood pressure i.e., SBP 120-150 mmHg or DBP 80-90 mmHg inside OT 4.Requiring general anesthesia with endotracheal intubation for intraabdominal surgery

Exclusion criteria

Exclusion criteria: 1.Presence SBP more than 150 mmHg or DBP more than 90 mmHg inside OT 2.Laparoscopic surgery, epidural analgesia use 3.History of ischemic heart disease, 4.cerebrovascular disease, impaired liver, or renal functions. 5.Patients with anticipated difficult airway. Patient having bradycardia (HR �50 beats/minute) and heart block 6.Patients with diabetic mellitus.

Design outcomes

Primary

MeasureTime frame
� Changes in blood pressure after infusion of dexmedetomidine before induction of anesthesia.Timepoint: Data will be taken baseline, 5 min after infusion, 10 min after infusion, 1 min after intubation, 5 min after intubation, at the time of incision, 15 min of incision, 30 min of infusion, 1min after extubation, 5 min after extubation

Secondary

MeasureTime frame
Hemodynamic response to intubation, intraoperative hemodynamic parameter, Amount of propofol necessary for induction, incidence of bradycardia, dry mouth and respiratory depression, PONV or any side effect of study drugs will be evaluated as secondary objective.Timepoint: maximum 48 hrs

Countries

India

Contacts

Public ContactProf Jyotsna Agarwal

King Georges Medical University Lucknow

dr.jyotsna@yahoo.co.in9415518399

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026